Drug Shortage Report for APPRILON
Report ID | 204639 |
Drug Identification Number | 02375885 |
Brand name | APPRILON |
Common or Proper name | doxycycline |
Company Name | GALDERMA CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | DOXYCYCLINE |
Strength(s) | 40MG |
Dosage form(s) | CAPSULE (IMMEDIATE AND DELAYED RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 40 mg, 28 capsules |
ATC code | J01AA |
ATC description | TETRACYCLINES |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2023-09-28 |
Actual start date | |
Estimated end date | 2023-10-20 |
Actual end date | 2023-10-17 |
Shortage status | Resolved |
Updated date | 2023-10-18 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 55 COMMERCE VALLEY DRIVE WEST THORNHILL, ONTARIO CANADA L3T 7V9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v11 | 2023-10-18 | English | Compare |
v10 | 2023-10-17 | French | Compare |
v9 | 2023-10-17 | English | Compare |
v8 | 2023-10-16 | French | Compare |
v7 | 2023-10-16 | English | Compare |
v6 | 2023-10-13 | French | Compare |
v5 | 2023-10-13 | English | Compare |
v4 | 2023-09-29 | English | Compare |
v3 | 2023-09-18 | French | Compare |
v2 | 2023-09-18 | English | Compare |
v1 | 2023-09-18 | English | Compare |
Showing 1 to 11 of 11